232 related articles for article (PubMed ID: 24533448)
1. N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes.
Moazzen H; Lu X; Ma NL; Velenosi TJ; Urquhart BL; Wisse LJ; Gittenberger-de Groot AC; Feng Q
Cardiovasc Diabetol; 2014 Feb; 13():46. PubMed ID: 24533448
[TBL] [Abstract][Full Text] [Related]
2. Sapropterin Treatment Prevents Congenital Heart Defects Induced by Pregestational Diabetes Mellitus in Mice.
Engineer A; Saiyin T; Lu X; Kucey AS; Urquhart BL; Drysdale TA; Norozi K; Feng Q
J Am Heart Assoc; 2018 Nov; 7(21):e009624. PubMed ID: 30608180
[TBL] [Abstract][Full Text] [Related]
3. Say NO to ROS: Their Roles in Embryonic Heart Development and Pathogenesis of Congenital Heart Defects in Maternal Diabetes.
Engineer A; Saiyin T; Greco ER; Feng Q
Antioxidants (Basel); 2019 Oct; 8(10):. PubMed ID: 31581464
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential of N-Acetylcysteine for Wound Healing, Acute Bronchiolitis, and Congenital Heart Defects.
AlMatar M; Batool T; Makky EA
Curr Drug Metab; 2016; 17(2):156-67. PubMed ID: 26651980
[TBL] [Abstract][Full Text] [Related]
5. Maternal voluntary exercise mitigates oxidative stress and incidence of congenital heart defects in pre-gestational diabetes.
Saiyin T; Engineer A; Greco ER; Kim MY; Lu X; Jones DL; Feng Q
J Cell Mol Med; 2019 Aug; 23(8):5553-5565. PubMed ID: 31211496
[TBL] [Abstract][Full Text] [Related]
6. Fetal cardiac effects of maternal hyperglycemia during pregnancy.
Corrigan N; Brazil DP; McAuliffe F
Birth Defects Res A Clin Mol Teratol; 2009 Jun; 85(6):523-30. PubMed ID: 19180650
[TBL] [Abstract][Full Text] [Related]
7. Pregestational diabetes induces fetal coronary artery malformation via reactive oxygen species signaling.
Moazzen H; Lu X; Liu M; Feng Q
Diabetes; 2015 Apr; 64(4):1431-43. PubMed ID: 25422104
[TBL] [Abstract][Full Text] [Related]
8. Anatomy of the ventricular septal defect in congenital heart defects: a random association?
Mostefa-Kara M; Houyel L; Bonnet D
Orphanet J Rare Dis; 2018 Jul; 13(1):118. PubMed ID: 30021599
[TBL] [Abstract][Full Text] [Related]
9. Risk of congenital heart defects in offspring exposed to maternal diabetes mellitus: an updated systematic review and meta-analysis.
Chen L; Yang T; Chen L; Wang L; Wang T; Zhao L; Ye Z; Zhang S; Luo L; Zheng Z; Qin J
Arch Gynecol Obstet; 2019 Dec; 300(6):1491-1506. PubMed ID: 31713644
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study.
Tennstedt C; Chaoui R; Körner H; Dietel M
Heart; 1999 Jul; 82(1):34-9. PubMed ID: 10377306
[TBL] [Abstract][Full Text] [Related]
11. Impact of maternal obesity and maternal overweight on the detection rate of fetal heart defects and the image quality of prenatal echocardiography.
Uhden M; Knippel AJ; Stressig R; Hammer R; Siegmann H; Froehlich S; Kozlowski P
Ultraschall Med; 2011 Dec; 32 Suppl 2():E108-14. PubMed ID: 21877317
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and major subtypes of congenital heart defects in Hunan Province, China.
Xie D; Fang J; Liu Z; Wang H; Yang T; Sun Z; Wang A; Xiong L
Medicine (Baltimore); 2018 Aug; 97(31):e11770. PubMed ID: 30075604
[TBL] [Abstract][Full Text] [Related]
13. Perinatal outcomes and congenital heart defect prognosis in 53313 non-selected perinatal infants.
Xie D; Wang H; Liu Z; Fang J; Yang T; Zhou S; Wang A; Qin J; Xiong L
PLoS One; 2017; 12(6):e0177229. PubMed ID: 28591192
[TBL] [Abstract][Full Text] [Related]
14. N-Acetyl Cysteine improves the diabetic cardiac function: possible role of fibrosis inhibition.
Liu C; Lu XZ; Shen MZ; Xing CY; Ma J; Duan YY; Yuan LJ
BMC Cardiovasc Disord; 2015 Aug; 15():84. PubMed ID: 26242742
[TBL] [Abstract][Full Text] [Related]
15. Late-gestation ventricular myocardial reduction in fetuses of hyperglycemic CD1 mice is associated with increased apoptosis.
Gutierrez JC; Prater MR; Smith BJ; Freeman LE; Mallela MK; Holladay SD
Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):409-15. PubMed ID: 19851988
[TBL] [Abstract][Full Text] [Related]
16. Sex differences for major congenital heart defects in Down Syndrome: A population based study.
Santoro M; Coi A; Spadoni I; Bianchi F; Pierini A
Eur J Med Genet; 2018 Sep; 61(9):546-550. PubMed ID: 29753092
[TBL] [Abstract][Full Text] [Related]
17. Novel circRNA-miRNA-mRNA networks regulated by maternal exercise in fetal hearts of pregestational diabetes.
Ye F; Lu X; van Neck R; Jones DL; Feng Q
Life Sci; 2023 Feb; 314():121308. PubMed ID: 36563841
[TBL] [Abstract][Full Text] [Related]
18. The trends and patterns of congenital heart diseases at Madinah Cardiac Center, Madinah, Saudi Arabia.
Khoshhal SQ; Albasri AM; Morsy MMF; Alnajjar AA
Saudi Med J; 2020 Sep; 41(9):977-983. PubMed ID: 32893280
[TBL] [Abstract][Full Text] [Related]
19. Antifungal medication use during early pregnancy and the risk of congenital heart defects in the National Birth Defects Prevention Study, 1997-2011.
Papadopoulos EA; Howley MM; Fisher SC; Van Zutphen AR; Werler MM; Romitti PA; Browne ML;
Birth Defects Res; 2024 Feb; 116(2):e2308. PubMed ID: 38343154
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and congenital heart defects: a systematic review, meta-analysis, and modeling project.
Simeone RM; Devine OJ; Marcinkevage JA; Gilboa SM; Razzaghi H; Bardenheier BH; Sharma AJ; Honein MA
Am J Prev Med; 2015 Feb; 48(2):195-204. PubMed ID: 25326416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]